Form D · Biotechnology

SYNERGY PHARMACEUTICALS, INC.

New York, NY · CIK 001347613

Offering snapshot reported Nov 18, 2009 · SEC filing

Reported sold
$15.9M
Offering amount: $18.2M
Investors reported
45
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 12, 2009
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$7.94M$15.9MJul 10, 2009: $7,092,500.00Jul 10, 2009Nov 18, 2009: $15,870,000.00Nov 18, 2009

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$7,092,500 → $15,870,000
  • Reported investors16 → 45

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 18, 2009Amendment$15,870,000$8,777,500vs Jul 10, 200945SEC filing
Jul 10, 2009Initial$7,092,500No comparison16SEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$235K
Form D file number
021-84127

Source: Form D, filed Nov 18, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Thomas H. Adams Director
John Brancaccio Director
Gabriele M. Cerrone Director
Bernard Denoyer Executive
Gary S. Jacob Director, Executive
Kunwar Shailubhai Executive
Melvin K. Spigelman Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
420 Lexington Avenue Suite 1609
New York, NY, 10170